tm logo
ENTOS
Live/Registered
REGISTERED

on 29 Aug 2023

Last Applicant/ Owned by

4470 W Sunset Blvd, Suite 107 PMB 94758

Los Angeles

CA

90027

Serial Number

90894329 filed on 20th Aug 2021

Registration Number

7151783 registered on 29th Aug 2023

in the Principal Register

Correspondent Address

Alyssa M. Worsham

Alyssa M. Worsham

650 PAGE MILL ROAD

PALO ALTO, CA 94304

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ENTOS

research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products


First Use Date in General

03rd Oct 2013

First Use Date in Commerce

03rd Oct 2013

Mark Details


Serial Number

No 90894329

Mark Type

No Service Mark

Attorney Docket Number

No 59215-TM1001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Aug 2023REGISTERED-PRINCIPAL REGISTER
29th Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
27th Jul 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26th Jul 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25th Jul 2023STATEMENT OF USE PROCESSING COMPLETE
24th Jul 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Jun 2023TEAS STATEMENT OF USE RECEIVED
30th Jun 2023USE AMENDMENT FILED
13th Jun 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04th May 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED